Credit Suisse (SIX:CSGN) analyst A.J. Rice maintained a Buy rating on Encompass Health (NYSE:EHC) Corporation on Monday, setting a price target of $89, which is approximately 34.77% above the present share price of $66.04.
Rice expects Encompass Health Corporation to post earnings per share (EPS) of $0.88 for the third quarter of 2020.
The current consensus among 7 TipRanks analysts is for a Moderate Buy rating of shares in Encompass Health, with an average price target of $82.43.
The analysts price targets range from a high of $89 to a low of $60.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $1.18 billion and a net profit of $180.2 million. The company's market cap is $6.64 billion.
According to TipRanks.com, Credit Suisse analyst A.J. Rice is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 6.1% and a 59.21% success rate.
Encompass Health Corp. engages in providing post-acute healthcare services. It operates through the following segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac & pulmonary conditions, brain & spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.